ストックスクリーナーアプリを入手
10.46
4.29%
0.43
アフターアワーズ：
10.46
前日終値:
$10.03
開ける：
$10
24時間の取引高:
1.06M
Relative Volume:
0.69
時価総額：
$949.77M
収益：
$2.98B
当期純損益:
$-300.00M
株価収益率:
-3.0765
EPS:
-3.4
ネットキャッシュフロー:
$225.00M
1週間 パフォーマンス:
-7.43%
1か月 パフォーマンス:
+24.23%
6か月 パフォーマンス:
+67.90%
1年 パフォーマンス:
-37.81%
1日の値動き範囲:
$9.72
$10.47
1週間の範囲:
$9.72
$11.44
52週間の値動き範囲:
$3.97
$25.28
Fortrea Holdings Inc Stock (FTRE) Company Profile
FTRE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FTRE
Fortrea Holdings Inc
|
10.46 | 910.72M | 2.98B | -300.00M | 225.00M | -3.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Fortrea Holdings Inc Stock (FTRE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-04 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2025-05-02 | 開始されました | Truist | Hold |
| 2025-04-10 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2024-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-12-06 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-09-25 | ダウングレード | Jefferies | Buy → Hold |
| 2024-08-08 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2024-07-24 | 再開されました | Barclays | Equal Weight |
| 2024-06-06 | 開始されました | Goldman | Neutral |
| 2024-05-29 | 開始されました | TD Cowen | Hold |
| 2024-05-28 | 開始されました | Mizuho | Neutral |
| 2024-03-22 | 開始されました | Robert W. Baird | Neutral |
| 2024-03-06 | 開始されました | Deutsche Bank | Hold |
| 2024-01-05 | 開始されました | William Blair | Mkt Perform |
| 2024-01-04 | 開始されました | Jefferies | Buy |
| 2023-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2023-12-01 | アップグレード | Evercore ISI | In-line → Outperform |
| 2023-11-14 | アップグレード | Barclays | Equal Weight → Overweight |
| 2023-10-19 | 開始されました | Citigroup | Neutral |
| 2023-09-14 | 開始されました | Evercore ISI | In-line |
| 2023-08-16 | 開始されました | Barclays | Equal Weight |
| 2023-08-07 | 開始されました | BofA Securities | Underperform |
すべてを表示
Fortrea Holdings Inc (FTRE) 最新ニュース
Why The Narrative Around Fortrea Holdings Is Shifting Amid New Analyst and Business Updates - Yahoo Finance
How Fortrea Holdings Inc. stock performs in high volatility markets2025 Winners & Losers & Detailed Earnings Play Strategies - newser.com
Is Fortrea Holdings Inc. stock a buy before product launches2025 Historical Comparison & AI Enhanced Trading Signals - newser.com
Advanced analytics toolkit walkthrough for Fortrea Holdings Inc.IPO Watch & Risk Controlled Swing Alerts - newser.com
Is Fortrea Holdings Inc. stock a buy for dividend growthTrade Ideas & Verified Technical Trade Signals - newser.com
Will Fortrea Holdings Inc. (K67) stock extend growth story2025 Fundamental Recap & AI Driven Stock Price Forecasts - newser.com
Can Fortrea Holdings Inc. (K67) stock sustain revenue momentumRate Hike & Safe Capital Growth Trade Ideas - newser.com
Will earnings trigger a reversal in Fortrea Holdings Inc.July 2025 Setups & AI Enhanced Trading Signals - newser.com
Multi asset correlation models including Fortrea Holdings Inc.Quarterly Growth Report & High Accuracy Buy Signal Tips - newser.com
Is Fortrea Holdings Inc. (K67) stock a contrarian opportunityWeekly Earnings Recap & Verified Short-Term Plans - newser.com
Fortrea Reports Second Quarter 2025 Results - ADVFN
Mutual of America Capital Management LLC Has $57,000 Holdings in Fortrea Holdings Inc. $FTRE - MarketBeat
Momentum divergence signals in Fortrea Holdings Inc. chartWeekly Gains Report & Reliable Intraday Trade Plans - newser.com
Using economic indicators to assess Fortrea Holdings Inc. potential2025 Major Catalysts & High Conviction Trade Alerts - newser.com
Fortrea Holdings Inc. (FTRE) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Fortrea and GE Healthcare’s New Diagnostic Study: A Potential Game-Changer in Cancer Detection - TipRanks
Fortrea (FTRE) to Release Earnings on Wednesday - MarketBeat
Fortrea’s New Clinical Trial: A Game Changer in Spinal Surgery? - MSN
Fortrea Holdings Inc. (FTRE) Stock forecasts - Yahoo! Finance UK
Fortrea Holdings Inc. (FTRE) Stock Forecasts - Yahoo! Finance Canada
Fortrea’s Givinostat Study: A New Hope for Young DMD Patients - TipRanks
What drives Fortrea Holdings Inc K67 stock priceTechnical Resistance Breaks & Plan Your Exit as You Enter – Risk First - earlytimes.in
Exploring October 2025's Top Undervalued Small Caps With Insider Activity - simplywall.st
Fortrea Holdings Meets 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily
Fortrea’s Givinostat Study: A Potential Game-Changer for Duchenne Muscular Dystrophy - MSN
What Fortrea Holdings (FTRE)'s Debt Tender, Legal Scrutiny Mean for Investor Confidence - simplywall.st
Fortrea (NASDAQ:FTRE) Shares Down 6.9% After Analyst Downgrade - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fortrea Holdings, Inc. (FTRE) And Encourages Investors to Reach Out - ACCESS Newswire
Fortrea Holdings, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Fluctuations - Markets Mojo
Is Fortrea Holdings Inc. stock attractive for income investors2025 Support & Resistance & Verified Short-Term Plans - Fundação Cultural do Pará
Fortrea’s Phase 1 Study on D3S-001: Evaluating Food’s Impact on Drug Absorption - TipRanks
Fortrea’s Phase 3 Study on AP301: A Potential Game-Changer for Hyperphosphatemia Treatment - TipRanks
Fortrea’s Phase 1 PET Study: A Potential Game-Changer in Diagnostic Imaging - TipRanks
Fortrea Holdings Inc (FTRE) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):